Distribution to erythrocytes of Methylphenidate [Bioanalytics]

posted by Ohlbe – France, 2019-01-06 20:07 (2374 d 13:43 ago) – Posting: # 19736
Views: 2,955

Dear EKY,

❝ According to available data that methylphenidate and its metabolites are distributed between plasma (57%) and erythrocytes (43%) in blood.


If I interpret correctly what you wrote, concentrations are comparable in plasma and erythrocytes. So hemolysis will not release massive amounts of the drug or metabolites in plasma, contrary to e.g. ciclosporine.

❝ Can the respective plasma concentrations from hemolysis samples be fallacious?


Yes, possibly, by other ways. If you are using LC-MS/MS, you may have differences in matrix effects in hemolysed samples, but you are supposed to check for this during method validation. If you are using HPLC/UV, you may get chromatographic interferences. Whatever the method, you may have problems with recovery, or with analyte stability (see for instance this paper).

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,690 registered users;
100 visitors (0 registered, 100 guests [including 13 identified bots]).
Forum time: 10:51 CEST (Europe/Vienna)

Anyone who conducts an argument by appealing to authority
is not using his intelligence;
he is just using his memory.    Leonardo da Vinci

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5